Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Molecular Detection Kit Assessed for African Trypanosomiasis

By Labmedica International staff writers
Posted on 31 Oct 2013
Image: Loopamp Realtime Turbidimeter for Loop-mediated Isothermal Amplification (Photo courtesy of Eiken Chemical).
Image: Loopamp Realtime Turbidimeter for Loop-mediated Isothermal Amplification (Photo courtesy of Eiken Chemical).
Molecular methods have great potential for sensitive parasite detection in the diagnosis of human African trypanosomiasis (HAT), but the requirements in terms of laboratory infrastructure limit their use to reference centers.

A recently develop commercial assay that uses loop mediated isothermal amplification (LAMP) has been transformed into a ready-to-use kit format that does not require thermocyclers and amplification and can be conducted in a heating block or a hot water bath.

Tropical medicine specialists at the Institute of Tropical Medicine (Antwerp, Belgium) working with colleagues at the Kinshasa University (Kinshasa, Democratic Republic of the Congo) evaluated the diagnostic performance of the Loopamp Trypanosoma brucei assay (LAMP) in confirmed T.b. gambiense HAT patients, HAT suspects and healthy endemic controls from the Democratic Republic of the Congo (DRC).

Archived DNA from blood samples from 142 T. b. gambiense HAT patients, 111 healthy endemic controls and 97 HAT suspects with unconfirmed status were included in a retrospective evaluation. The Loopamp Trypanosoma brucei Detection Kit (Eiken Chemical; Tokyo, Japan) was applied in duplicate on the DNA extracts. LAMP amplified T. brucei DNA was visualized using the provided ultraviolet-light emitted diode (UV-LED) device. Amplified DNA emits green fluorescence while there is no fluorescence in negative samples.

Of the 142 HAT patients, 132 and 124 were LAMP positive in respectively the first and second run, corresponding with sensitivities of 93.0% and 87.3%. Of the 11 patients with trypanosomes detected only in lymph or in cerebral spinal fluid (CSF), seven were positive in both LAMP runs on blood. Of the 97 HAT suspects, six were positive in both replicates of LAMP, eight and 20 were positive in the first and second replicate, respectively. Of 111 healthy endemic controls, four tested positive twice with LAMP and four tested positive only once.

The authors concluded that the LAMP has similar diagnostic accuracy as the 18S ribosomal DNA (rDNA) polymerase chain reaction (PCR) and can replace PCR for accurate and simplified detection of Trypanozoon DNA in clinical specimens. LAMP showed good diagnostic accuracy and excellent reproducibility, and may have an important role to play in disease surveillance. However, it should be noted that the specificity of LAMP is not 100%, that HAT treatment is complex and toxic, and that the positive predictive value of tests is low in hypoendemic settings. The study was published on October 17, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Institute of Tropical Medicine
Kinshasa University 
Eiken Chemical 



EUROIMMUN AG
Sekisui Diagnostics
PURITAN MEDICAL
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: Enzyme-linked immunosorbent kit (ELISA) specific for human copeptin (Photo courtesy of USCN Life Science).

Preeclampsia Biomarker Detected Very Early In Pregnancy

A biomarker has been discovered that could give expecting mothers and their doctors the first simple blood test to reliably predict that a pregnant woman may develop preeclampsia, at least as early as... Read more

Pathology

view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

Brain Tumor Chemotherapy Biomarkers Identified

Cancer researchers have identified a new biomarker that they believe can predict whether glioblastoma multiformes (GBMs), the most common and aggressive type of malignant brain tumor, will be susceptible... Read more

Lab Tech.

view channel
Image: The ADVIA Centaur XPT Immunoassay System delivers the results that clinicians depend upon for accurate diagnoses and better patient care (Photo courtesy of Siemens Healthcare).

Introduction of New Central Laboratory Clinical Analyzers Highlights Recent Lab Equipment Exposition

An impressive array of new automated analyzers for central diagnostic laboratories was unveiled at a recent lab equipment trade fair. The IFCC WorldLab exposition held June 22-26, 2014, in Istanbul... Read more

Industry News

view channel

EKF Wins Distribution Contract and Regulatory Approval for Target Regions

EKF Diagnostics Holdings (Cardiff, Wales, UK), an AIM-listed point-of-care, central laboratory and molecular diagnostics business, announced that it has signed a new distribution contract in China and that one of its OEM (original equipment manufacturer) partners has received further regulatory approval across several target... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.